Abstract
We investigated the effects of anandamide on peroxisome proliferator-activated receptor γ (PPARγ) activity. In two different transactivation systems using either full-length or only the ligand binding domain of PPARγ, we showed that anandamide, but not palmitoylethanolamide induced transcriptional activation of PPARγ in a dose dependent manner with an EC 50 of 8 μM. In addition, competition binding experiments showed that anandamide but not palmitoylethanolamide binds directly to PPAR-ligand binding domain. We also found that anandamide treatment induced 3T3-L1 fibroblast differentiation into adipocytes. Indeed, anandamide induced triglyceride droplet accumulation and the expression of PPARγ responsive genes such as CCAAT enhancer binding protein α (C-EBPα), aP2, PerilipinA and Acrp30. Furthermore, the PPARγ antagonist (GW9662) inhibited the anandamide-induced 3T3-L1 differentiation confirming that this is a PPARγ-mediated process. Altogether, these data indicate that anandamide binds PPARγ and induces cellular PPARγ signaling.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
